Paper229357
Reconstituted low density lipoprotein: a vehicle for the delivery of hydrophobic fluorescent probes to cells.
Krieger M and 7 others. J Supramol Struct, 1979. Cited by 97 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Reconstituted low density lipoprotein: a vehicle for the delivery of hydrophobic fluorescent probes to cells. Papers, record 229357. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/229357
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Reconstituted low density lipoprotein: a vehicle for the delivery of hydrophobic fluorescent probes to cells.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lipoproteins, LDL | Major topic |
| Cells, Cultured | |
| Fibroblasts | |
| Fluorescent Dyes | |
| Humans | |
| Hypercholesterolemia | |
| Protein Binding | |
| Receptors, Drug | |
| Spectrometry, Fluorescence |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 97 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41967385 | Enhanced delivery of low-density lipoprotein-based nanoparticles to the mouse glioblastoma using focused ultrasound as a novel therapy. | Biomaterials | 2026 | https://conductscience.org/library/papers/41967385 | PubMed |
| 39056024 | Extracellular vesicle and lipoprotein diagnostics (ExoLP-Dx) with membrane sensor: A robust microfluidic platform to overcome heterogeneity. | Biomicrofluidics | 2024 | https://conductscience.org/library/papers/39056024 | PubMed |
| 36798503 | Low-density lipoprotein: a versatile nanoscale platform for targeted delivery. | Nanoscale Adv | 2023 | https://conductscience.org/library/papers/36798503 | PubMed |
| 30806568 | Nanoparticle systems for cancer vaccine. | Nanomedicine (Lond) | 2019 | https://conductscience.org/library/papers/30806568 | PubMed |
| 29104991 | Biomimetics: reconstitution of low-density lipoprotein for targeted drug delivery and related theranostic applications. | Chem Soc Rev | 2017 | https://conductscience.org/library/papers/29104991 | PubMed |
| 28377633 | VLDL/LDL acts as a drug carrier and regulates the transport and metabolism of drugs in the body. | Sci Rep | 2017 | https://conductscience.org/library/papers/28377633 | PubMed |
| 28342772 | Elucidating the structural organization of a novel low-density lipoprotein nanoparticle reconstituted with docosahexaenoic acid. | Chem Phys Lipids | 2017 | https://conductscience.org/library/papers/28342772 | PubMed |
| 26180001 | Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging. | Curr Med Chem | 2015 | https://conductscience.org/library/papers/26180001 | PubMed |
| 25346461 | Learning from biology: synthetic lipoproteins for drug delivery. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2015 | https://conductscience.org/library/papers/25346461 | PubMed |
| 23248300 | A link between host plant adaptation and pesticide resistance in the polyphagous spider mite Tetranychus urticae. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23248300 | PubMed |
| 21557543 | Lipoprotein-inspired nanoparticles for cancer theranostics. | Acc Chem Res | 2011 | https://conductscience.org/library/papers/21557543 | PubMed |
| 18203443 | Naphthalocyanine-reconstituted LDL nanoparticles for in vivo cancer imaging and treatment. | Int J Nanomedicine | 2007 | https://conductscience.org/library/papers/18203443 | PubMed |
| 17200716 | Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17200716 | PubMed |
| 9601074 | Direct observation of lipoprotein cholesterol ester degradation in lysosomes. | Biochem J | 1998 | https://conductscience.org/library/papers/9601074 | PubMed |
| 8347487 | Low density lipoprotein for cytotoxic drug targeting: improved activity of elliptinium derivative against B16 melanoma in mice. | Br J Cancer | 1993 | https://conductscience.org/library/papers/8347487 | PubMed |
| 8297338 | Low-density lipoprotein as a transporter of dolichol intermediates in the mammalian circulation. | Biochem J | 1994 | https://conductscience.org/library/papers/8297338 | PubMed |
| 6853599 | Visualization of the binding, endocytosis, and transcytosis of low-density lipoprotein in the arterial endothelium in situ. | J Cell Biol | 1983 | https://conductscience.org/library/papers/6853599 | PubMed |
| 6272315 | Targeted killing of cultured cells by receptor-dependent photosensitization. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6272315 | PubMed |
| 6270157 | Fluorescent low density lipoprotein for observation of dynamics of individual receptor complexes on cultured human fibroblasts. | J Cell Biol | 1981 | https://conductscience.org/library/papers/6270157 | PubMed |
| 6264440 | Colloidal gold--low density lipoprotein conjugates as membrane receptor probes. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6264440 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/229357
GET https://conductscience.org/api/papers/v1/229357/cited_by?page=2